PDGFRB and glioblastoma: Similarly, the DNA aptamer Gint4.T targets PDGFRβ—a key growth driver in mesenchymal GBM—and not only binds the receptor but also interferes with its activity, effectively acting as an anti-cancer agent on its own.37